The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence
Open accessAbstract
◼ pulmonary embolism ◼ thrombosis ◼ von Willebrand factor W e report a case series of patients with coronavirus disease 2019 (CO-VID-19) with pulmonary embolism (PE) in our institution.Lille University Hospital is the tertiary care center for the North of France, the second greatest French region in population density (189 people per 1 km 2 ), also considered a metabolic area with high number of overweight patients.The study was approved by the institutional data protection authority of Lille University Hospital.Among the 107 first consecutive patients with confirmed COVID-19 admitted to the intensive care unit (ICU) for pneumonia from February 27 to March 31, we noticed an unexpectedly high number of PEs during their stay in the ICU: 22 (20.6%) at the time of analysis (April 9), within a median time from ICU admission of 6 days (range, 1-18 days).To determine whether this represents an increase in the expected incidence of PE over a similar time interval, we analyzed the files of 196 patients hospitalized in our ICU during the same time interval in 2019.Despite a similar severity score on admittance to the ICU, the frequency of PE in our CO-VID-19 series was twice as high as the frequency we found in this control period (20.6% versus 6.1%; absolute increased risk, 14.4% [95% CI, 6.1-22.8]).It was also twice as high as the 7.5% frequency of PE in the 40 patients with influenza admitted to the ICU between January 1 and December 30, 2019 (3 PEs; absolute increased risk, 13.1% [95% CI, 1.9-24.3]).A qualitative description of the main characteristics of the patients with PE in the different periods is given in the Table.Taking into account the ICU duration at time of analysis, we estimated the cumulative incidence of PE using the Kalbfleisch and Prentice method by taking into account death (n=15) and discharged alive (n=48) as competing events.The 22 patients still hospitalized in the ICU without PE at the time of analysis (median ICU length of stay, 15 days; range, 10-30 days) were treated as censored observations.At day 15 of ICU admission, the cumulative incidence of PE in patients with COVID-19 in the ICU was estimated to be 20.4% (95% CI, 13.1-28.7).In terms of the main data at ICU admission (using the univariable Fine and Gray model to estimate subhazard ratios of PE), D-dimers (estimate subhazard ratio per log-SD increase, 1.81 [95% CI,1.03-3.16]),plasma factor VIII activity (estimate subhazard ratio per log-SD increase,1.73 [95% CI, 1.10-2.72]),and von Willebrand factor antigen (estimate subhazard ratio per log-SD increase,1.69[95% CI, 1.12-2.56])values seem to be associated with a greater PE risk.At the time of PE diagnosis, 20 of 22 patients were receiving prophylactic antithrombotic treatment (unfractionated heparin or low-molecular-weight heparin) according to the current guidelines in critically ill patients.1,2 One patient with a history of deep venous thrombosis was receiving fluindione with an international normalized ratio in the therapeutic range, and 1 patient was receiving therapeutic unfractionated heparin because of atrial fibrillation.The criteria for deciding to perform computed tomography pulmonary angiography (CTPA) were suspicion of PE
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Simonnet, A., Chetboun, M., Poissy, J., Raverdy, V., Noulette, J., Duhamel, A., Labreuche, J., Mathieu, D., Pattou, F., Jourdain, M., et al. (2020) · Obesity · doi:10.1002/oby.22831 · Cited by 2,079
Self-citationSchünemann, H. J., Cushman, M., Burnett, A. E., Kahn, S. R., Beyer-Westendorf, J., Spencer, F. A., Rezende, S. M., Zakai, N. A., Bauer, K. A., Dentali, F., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018022954 · Cited by 819
The versatile heparin in COVID-19
Thachil, J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14821 · Cited by 404
Obi, A. T., Tignanelli, C. J., Jacobs, B. N., Arya, S., Park, P. K., Wakefield, T. W., Henke, P. K., & Napolitano, L. M. (2019) · Journal of Vascular Surgery: Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2018.08.010 · Cited by 166
Cited by
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Extrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185
Bourgonje, A. R., Abdulle, A. E., Timens, W., Hillebrands, J., Navis, G. J., Gordijn, S. J., Bolling, M. C., Dijkstra, G., Voors, A. A., Osterhaus, A. D., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5471 · Cited by 1,081
Interplay between inflammation and thrombosis in cardiovascular pathology
Stark, K., & Massberg, S. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00552-1 · Cited by 1,033
Platelet gene expression and function in patients with COVID-19
Manne, B. K., Denorme, F., Middleton, E. A., Portier, I., Rowley, J. W., Stubben, C., Petrey, A. C., Tolley, N. D., Guo, L., Cody, M., et al. (2020) · Blood · doi:10.1182/blood.2020007214 · Cited by 946
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
The REMAP-CAP, A.-4. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2103417 · Cited by 941
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators (2021) · Intensive Care Medicine · doi:10.1007/s00134-020-06294-x · Cited by 924
Malas, M. B., Naazie, I. N., Elsayed, N., Mathlouthi, A., Marmor, R., & Clary, B. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100639 · Cited by 685
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
Zhang, S., Liu, Y., Wang, X., Yang, L., Li, H., Wang, Y., Liu, M., Zhao, X., Xie, Y., Yang, Y., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00954-7 · Cited by 657
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019
Moores, L. K., Tritschler, T., Brosnahan, S., Carrier, M., Collen, J. F., Doerschug, K., Holley, A. B., Jimenez, D., Le Gal, G., Rali, P., et al. (2020) · Chest · doi:10.1016/j.chest.2020.05.559 · Cited by 638
Sardu, C., Gambardella, J., Morelli, M. B., Wang, X., Marfella, R., & Santulli, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051417 · Cited by 592
Iba, T., Levy, J. H., Levi, M., & Thachil, J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14975 · Cited by 585
Coagulopathy of Coronavirus Disease 2019
Iba, T., Levy, J. H., Levi, M., Connors, J. M., & Thachil, J. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004458 · Cited by 534
Rapkiewicz, A. V., Mai, X., Carsons, S. E., Pittaluga, S., Kleiner, D. E., Berger, J. S., Thomas, S., Adler, N. M., Charytan, D. M., Gasmi, B., et al. (2020) · eClinicalMedicine · doi:10.1016/j.eclinm.2020.100434 · Cited by 533
Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis
Nopp, S., Moik, F., Jilma, B., Pabinger, I., & Ay, C. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12439 · Cited by 489
Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis
Suh, Y. J., Hong, H., Ohana, M., Bompard, F., Revel, M.-P., Valle, C., Gervaise, A., Poissy, J., Susen, S., Hékimian, G., et al. (2021) · Radiology · doi:10.1148/radiol.2020203557 · Cited by 489
Self-citationIncidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019
Jiménez, D., García-Sanchez, A., Rali, P., Muriel, A., Bikdeli, B., Ruiz-Artacho, P., Le Mao, R., Rodríguez, C., Hunt, B. J., & Monreal, M. (2021) · Chest · doi:10.1016/j.chest.2020.11.005 · Cited by 468
Spyropoulos, A. C., Goldin, M., Giannis, D., Diab, W., Wang, J., Khanijo, S., Mignatti, A., Gianos, E., Cohen, M., Sharifova, G., et al. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.6203 · Cited by 461
Schmidt, M., Hajage, D., Lebreton, G., Monsel, A., Voiriot, G., Levy, D., Baron, E., Beurton, A., Chommeloux, J., Meng, P., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30328-3 · Cited by 458
Multisystem inflammatory syndrome in children related to COVID-19: a systematic review
Hoste, L., Van Paemel, R., & Haerynck, F. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-021-03993-5 · Cited by 455
Baj, J., Karakuła-Juchnowicz, H., Teresiński, G., Buszewicz, G., Ciesielka, M., Sitarz, R., Forma, A., Karakuła, K., Flieger, W., Portincasa, P., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061753 · Cited by 453
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
Gu, S. X., Tyagi, T., Jain, K., Gu, V. W., Lee, S. H., Hwa, J. M., Kwan, J. M., Krause, D. S., Lee, A. I., Halene, S., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00469-1 · Cited by 418
Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract
Flerlage, T., Boyd, D. F., Meliopoulos, V., Thomas, P. G., & Schultz-Cherry, S. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00542-7 · Cited by 402
Thrombosis risk associated with COVID-19 infection. A scoping review
Al-Ani, F., Chehade, S., & Lazo-Langner, A. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.05.039 · Cited by 400
COVID-19 and liver disease: mechanistic and clinical perspectives
Marjot, T., Webb, G. J., Barritt, A. S., Moon, A. M., Stamataki, Z., Wong, V. W., & Barnes, E. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00426-4 · Cited by 385
MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19
Bilezikian, J. P., Bikle, D., Hewison, M., Lazaretti-Castro, M., Formenti, A. M., Gupta, A., Madhavan, M. V., Nair, N., Babalyan, V., Hutchings, N., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0665 · Cited by 343
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
Huertas, A., Montani, D., Savale, L., Pichon, J., Tu, L., Parent, F., Guignabert, C., & Humbert, M. (2020) · European Respiratory Journal · doi:10.1183/13993003.01634-2020 · Cited by 340
Hanff, T. C., Mohareb, A. M., Giri, J., Cohen, J. B., & Chirinos, J. A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25982 · Cited by 312
Chow, J. H., Khanna, A. K., Kethireddy, S., Yamane, D., Levine, A., Jackson, A. M., McCurdy, M. T., Tabatabai, A., Kumar, G., Park, P., et al. (2021) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005292 · Cited by 309
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies
Di Minno, A., Ambrosino, P., Calcaterra, I., & Di Minno, M. N. D. (2020) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0040-1715456 · Cited by 300
Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis
Tan, B. K., Mainbourg, S., Friggeri, A., Bertoletti, L., Douplat, M., Dargaud, Y., Grange, C., Lobbes, H., Provencher, S., & Lega, J.-C. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-215383 · Cited by 290
Gorog, D. A., Storey, R. F., Gurbel, P. A., Tantry, U. S., Berger, J. S., Chan, M. Y., Duerschmied, D., Smyth, S. S., Parker, W. A. E., Ajjan, R. A., et al. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00665-7 · Cited by 286
Costa, V. D. O., de Almeida, G. B. C., Nicolini, E. M., Rodrigues, G. D. A., da Costa, B. M. A., Carvalho, G. H., dos Reis, Á. L. S., & Colen, D. P. (2020) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2020.11.046 · Cited by 280
COVID-19 and Cancer: Current Challenges and Perspectives
Bakouny, Z., Hawley, J. E., Choueiri, T. K., Peters, S., Rini, B. I., Warner, J. L., & Painter, C. A. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.09.018 · Cited by 275
Földi, M., Farkas, N., Kiss, S., Zádori, N., Váncsa, S., Szakó, L., Dembrovszky, F., Solymár, M., Bartalis, E., Szakács, Z., et al. (2020) · Obesity Reviews · doi:10.1111/obr.13095 · Cited by 271
Thrombotic complications of COVID-19
Avila, J., Long, B., Holladay, D., & Gottlieb, M. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.09.065 · Cited by 143
“Multiple reports have circulated demonstrating increased rates of thromboembolic events in patients with COVID-19 [4-11].”
He, L., Mäe, M. A., Muhl, L., Sun, Y., Pietilä, R., Nahar, K., Liébanas, E. V., Fagerlund, M. J., Oldner, A., Liu, J., et al. (2020) · doi:10.1101/2020.05.11.088500 · Cited by 116
Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism
Stefely, J. A., Christensen, B. B., Gogakos, T., Cone Sullivan, J. K., Montgomery, G. G., Barranco, J. P., & Van Cott, E. M. (2020) · American Journal of Hematology · doi:10.1002/ajh.25979 · Cited by 80
COVID-19 versus HIT hypercoagulability
Warkentin, T. E., & Kaatz, S. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.08.017 · Cited by 57
O'Shea, A., Parakh, A., Hedgire, S., & Lee, S. I. (2021) · American Journal of Roentgenology · doi:10.2214/ajr.20.24132 · Cited by 30
Devaux, C. A., & Camoin-Jau, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1042200 · Cited by 20
“High levels of D-dimers are found in ∼ 20–40% of critically ill COVID-19 patients (Poissy et al., 2020; Zhang Y. et al., 2020; Zhang S. et al., 2020; Xie et al., 2022).”
BackgroundMohammed Sheata, I., Smith, S. R., Kamel, H., Varrassi, G., Imani, F., Dayani, A., Myrcik, D., Urits, I., Viswanath, O., & Taha, S. S. (2021) · Anesthesiology and Pain Medicine · doi:10.5812/aapm.113752 · Cited by 16
From cellular function to global impact: the vascular perspective on COVID-19
Strauss, S. A., Seo, C., Carrier, M., & Jetty, P. (2021) · Canadian Journal of Surgery · doi:10.1503/cjs.023820 · Cited by 10
Metadata
- Authors
- Poissy, J., Goutay, J., Caplan, M., Parmentier, E., Duburcq, T., Lassalle, F., Jeanpierre, E., Rauch, A., Labreuche, J., Susen, S., Cousin, N., Durand, A., El Kalioubie, A., Favory, R., Girardie, P., Houard, M., Jaillette, E., Jourdain, M., Ledoux, G., Mathieu, D., Moreau, A.-S., Niles, C., Nseir, S., Onimus, T., Préau, S., Robriquet, L., Rouzé, A., Simonnet, A., Six, S., Toussaint, A., Dupont, A., Bauters, A., Zawadzki, C., Paris, C., Trillot, N., Wibaut, B., Hochart, A., Marichez, C., Dalibard, V., Vanderziepe, S., Bourgeois, L., Gaul, A., Jospin, A., Stepina, N., Pradines, B., Tournoys, A., Brousseau, T., Rémy, M., & Hutt, A.
- Venue
- Circulation
- Published
- 2020-07-14
- Volume
- 142
- Issue
- 2
- Pages
- 184-186
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3043049174
- Cited by
- 1,071
- References
- 5
- FWCI
- 29.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.